搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
World Fishing & Aquaculture
7 小时
Insect feeds approved for Label Rouge salmon
Industry partners drive legislative change - allowing natural insect-derived ingredients in feed and increase responsible ...
The Sunday Business Post
3 天
Blow to drinks companies as Irish alcohol labels get EU auditors’ seal of approval
Wine, beer and spirits makers say Ireland’s labels go too far and that a solo run could limit imports to the country ...
Nasdaq
4 天
Roche announces FDA approval of label expansion into biliary tract cancer
Roche (RHHBY) announced the FDA approval of a label expansion into biliary tract cancer, or BTC, for the Pathway anti-HER2/neu Rabbit Monoclonal Primary Antibody test. This test is now the first ...
4 天
BridgeBio: Next Chapter Begins After Attruby Approval
2025 will be a very eventful year for BridgeBio. In addition to the commercial launches of Attruby in the United States, ...
Rolling Out
20 小时
J. Cole reflects on winning JAY-Z’s powerful approval
Z's approval with Villematic and celebrates the release of his mixtape Friday Night Lights on streaming platforms.
BioSpace
5 天
BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition With Pfizer
BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a ...
Medscape
2 天
GLP-1 Labels Don’t Reflect Trial Exclusions
Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...
Winston-Salem Journal
3 天
Cigarette makers will have to add graphic labels in 2025
The labels, opposed by manufacturers including Reynolds, include images of diseased lungs and warning about erectile ...
4 天
Roche Gets FDA Approval For First Companion Diagnostic For HER2 Treatment In Biliary Tract ...
Roche (RHHBY) announced that the U.S. Food and Drug Administration has approved an expansion of the PATHWAY anti-HER2/neu (4B5) ...
1 天
ODAC to Discuss Exelixis' Application for Cabometyx Label Expansion
The FDA notified EXEL that its sNDA seeking label expansion of cabozantinib will be discussed at an ODAC meeting in March 2025.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈